^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

roniciclib (BAY1000394)

i
Associations
Company:
Bayer
Drug class:
CDK inhibitor
Associations
Phase 1
Bayer
Completed
Last update posted :
01/09/2017
Initiation :
08/01/2010
Primary completion :
06/01/2016
Completion :
12/01/2016
CASP3 • CDKN1A • ANXA5
|
MCL1 expression
|
roniciclib (BAY1000394)
Phase 2
Dana-Farber Cancer Institute
Withdrawn
Last update posted :
07/01/2016
Initiation :
02/01/2016
Primary completion :
10/01/2019
Completion :
05/01/2023
MYC • CCNE1 • MCL1
|
MYC amplification • CCNE1 amplification • MCL1 amplification
|
roniciclib (BAY1000394)